Medtronic plc

NYSE:MDT 주식 보고서

시가총액: US$110.6b

Medtronic 관리

관리 기준 확인 2/4

Medtronic CEO는 Geoff Martha, Apr2020 에 임명되었습니다 의 임기는 4.58 년입니다. 총 연간 보상은 $ 20.08M, 6.7% 로 구성됩니다. 6.7% 급여 및 93.3% 보너스(회사 주식 및 옵션 포함). 는 $ 6.66M 가치에 해당하는 회사 주식의 0.006% 직접 소유합니다. 6.66M. 경영진과 이사회의 평균 재임 기간은 각각 3.6 년과 7.8 년입니다.

주요 정보

Geoff Martha

최고 경영자

US$20.1m

총 보상

CEO 급여 비율6.7%
CEO 임기4.6yrs
CEO 소유권0.006%
경영진 평균 재임 기간3.6yrs
이사회 평균 재임 기간7.8yrs

최근 관리 업데이트

Recent updates

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Oct 31

Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Oct 13
Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Medtronic: Undervalued Dividend Aristocrat With High Margins

Oct 10

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Sep 30
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Sep 16
Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Sep 16

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Sep 05
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Is The Company Back?

Aug 26

Medtronic: Still A Buy Before Earnings

Aug 17

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Aug 08
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential

Jul 16

At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Jul 11
At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Jun 27
Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Medtronic: Why I Disagree With The Crowd

Jun 14

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

May 27

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

May 26
Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

May 22
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

May 13

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

May 01
Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

CEO 보상 분석

Geoff Martha 의 보수는 Medtronic 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Oct 25 2024n/an/a

US$4b

Jul 26 2024n/an/a

US$4b

Apr 26 2024US$20mUS$1m

US$4b

Jan 26 2024n/an/a

US$4b

Oct 27 2023n/an/a

US$4b

Jul 28 2023n/an/a

US$4b

Apr 28 2023US$15mUS$1m

US$4b

Jan 27 2023n/an/a

US$4b

Oct 28 2022n/an/a

US$4b

Jul 29 2022n/an/a

US$5b

Apr 29 2022n/an/a

US$5b

Jan 28 2022n/an/a

US$5b

Oct 29 2021n/an/a

US$5b

Jul 30 2021n/an/a

US$4b

Apr 30 2021US$18mUS$1m

US$4b

Jan 29 2021n/an/a

US$3b

Oct 30 2020n/an/a

US$4b

Jul 31 2020n/an/a

US$4b

Apr 24 2020US$6mUS$905k

US$5b

Jan 24 2020n/an/a

US$5b

Oct 25 2019n/an/a

US$5b

Jul 26 2019n/an/a

US$4b

Apr 26 2019US$4mUS$693k

US$5b

보상 대 시장: Geoff 의 총 보상 ($USD 20.08M )은 US 시장( $USD 12.66M ).

보상과 수익: Geoff 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Geoff Martha (54 yo)

4.6yrs

테뉴어

US$20,084,630

보상

Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Director of NextEra...

리더십 팀

이름위치테뉴어보상소유권
Geoffrey Martha
Chairman of the Board & CEO4.6yrsUS$20.08m0.0060%
$ 6.7m
Sean Salmon
Executive VP & President of Cardiovascular Portfoliono dataUS$6.55m0.0021%
$ 2.3m
Brett Wall
Executive VP & President of Neuroscience Portfolio5yrsUS$6.44m0.00092%
$ 1.0m
Gregory Smith
Executive Vice President of Global Operations & Supply Chain3.6yrsUS$7.66m0.0015%
$ 1.6m
Gary Corona
Senior Vice President of Global Financial Planning and Analysis & Interim CFOless than a year데이터 없음0.00045%
$ 497.6k
Mark Ploof
Senior Vice President of Global Operations and Business Services8.1yrs데이터 없음데이터 없음
Jennifer Kirk
Senior VP3.4yrs데이터 없음0.0022%
$ 2.5m
Kenneth Washington
Senior VP and Chief Technology & Innovation Officer1.4yrs데이터 없음데이터 없음
Laura Mauri
Senior VP and Chief Scientific & Medical Officer2.6yrs데이터 없음데이터 없음
Ryan Weispfenning
VP & Head of Investor Relations9.4yrs데이터 없음데이터 없음
Ivan Fong
Executive VP2.8yrsUS$11.72m0.0019%
$ 2.1m
Torod Neptune
Senior VP & Chief Communications Officer3.8yrs데이터 없음데이터 없음

3.6yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: MDT 의 관리팀은 경험 ( 3.6 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Geoffrey Martha
Chairman of the Board & CEO5yrsUS$20.08m0.0060%
$ 6.7m
Scott Donnelly
Independent Director11.8yrsUS$365.06k0.0012%
$ 1.3m
Kendall Powell
Independent Director17.8yrsUS$350.06k0.0015%
$ 1.7m
Randall Hogan
Independent Director9.8yrsUS$385.06k0.0034%
$ 3.7m
Craig Arnold
Lead Independent Director9.8yrsUS$410.06k0.0028%
$ 3.1m
Andrea Goldsmith
Independent Director5.7yrsUS$370.06k0.00048%
$ 530.7k
Elizabeth Nabel
Independent Director10.8yrsUS$370.06k0.0010%
$ 1.2m
Lidia Fonseca
Independent Director2.4yrsUS$350.06k0.00012%
$ 132.7k
Kevin Lofton
Independent Director4.2yrsUS$370.06k0.00032%
$ 353.8k
Gregory Lewis
Independent Director1.4yrsUS$306.97k0%
$ 0

7.8yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: MDT 의 이사회는 경험(평균 재직 기간 7.8 년)으로 간주됩니다.